Juvenile Angiofibroma: What Is on Stage?

2021 ◽  
Author(s):  
Maurizio Bignami ◽  
Giacomo Pietrobon ◽  
Alberto D. Arosio ◽  
Enrico Fazio ◽  
Larissa Nocchi Cardim ◽  
...  
Skull Base ◽  
2009 ◽  
Vol 19 (01) ◽  
Author(s):  
Ricardo Ramina ◽  
João Maniglia ◽  
Gustavo Nogueira ◽  
Charles Kondageski

2009 ◽  
Vol 73 (5) ◽  
pp. 689-692 ◽  
Author(s):  
Lechoslaw Pawel Chmielik ◽  
Magdalena Frackiewicz ◽  
Romuald Krajewski ◽  
Bogumila Woloszczuk-Gebicka ◽  
Mieczyslaw Chmielik

1969 ◽  
Vol 62 (8) ◽  
pp. 1003-1006 ◽  
Author(s):  
STEVEN S. COHENOUR ◽  
ARTHUR W. NUNNERY ◽  
BERKLEY S. EICHEL

2002 ◽  
Vol 112 (7) ◽  
pp. 1213-1220 ◽  
Author(s):  
Jivianne T. Lee ◽  
Peter Chen ◽  
Afshin Safa ◽  
Guy Juillard ◽  
Thomas C. Calcaterra

ORL ◽  
1979 ◽  
Vol 41 (6) ◽  
pp. 341-346
Author(s):  
Jörgen Lindström ◽  
Anders Tjellström ◽  
Hasse Ejnell

2018 ◽  
Vol 79 (01) ◽  
pp. 021-030 ◽  
Author(s):  
Ahmad Safadi ◽  
Alberto Schreiber ◽  
Dan Fliss ◽  
Piero Nicolai

AbstractJuvenile angiofibroma (JA) is a benign, highly vascular tumor which is diagnosed on the basis of clinical and imaging features. It has a characteristic pattern of spread commonly involving the pterygopalatine fossa and pterygoid base. The mainstay of treatment is surgery, while radiotherapy is rarely used for the treatment of recurrent lesion. Endoscopic endonasal surgery is currently the treatment of choice for small to intermediate size JAs, and is feasible even for advanced lesions; however, this should only be practiced in well-experienced centers.


2003 ◽  
Vol 32 (04) ◽  
pp. 211 ◽  
Author(s):  
Yi Zixiang ◽  
Li Zhi-Chun ◽  
Lin Chang ◽  
Ye Shengnan

Author(s):  
Ricardo L. Carrau ◽  
Carl H. Snyderman ◽  
Amin B. Kassam

1992 ◽  
Vol 21 (4) ◽  
pp. 230-232 ◽  
Author(s):  
Motoo Kitano ◽  
Gabriel Landini ◽  
Tamotsu Mimura

Sign in / Sign up

Export Citation Format

Share Document